GSK Wants Vaccine to Get to Those Who Need It Most First

The video discusses the availability and distribution of COVID vaccines, focusing on who should receive them first and the associated costs. It highlights GSK's commitment to global access, responsible pricing, and reinvestment of profits into pandemic preparedness. The challenges of manufacturing and distributing vaccines, especially in developing countries, are addressed. The video also covers contracts with governments and contributions to COVAX to ensure vaccines reach vulnerable populations.

What is one of the main concerns regarding the initial distribution of vaccines?

• The color of the vaccine packaging

• Who should receive the vaccine first

• The cost of the vaccine

• The effectiveness of the vaccine

What is a key principle of GSK regarding vaccine distribution?

• Focusing on a single vaccine solution

• Ensuring global access

• Limiting distribution to developed countries

• Maximizing profits

Why is distributing vaccines at minus 70 degrees challenging?

• It makes the vaccine more expensive

• It requires special packaging

• It is not suitable for some developing countries

• It increases the vaccine's effectiveness

What is GSK's stance on profiting from COVID vaccines during the pandemic?

• They aim to maximize profits

• They plan to break even

• They do not expect to profit

• They will increase prices

What is the purpose of GSK's commitment to 200 million doses for Kovacs?

• To increase their market share

• To support vulnerable populations in the developing world

• To test new vaccine technologies

• To supply vaccines to developed countries